<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719112466306</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719112466306</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Adhesion of <italic>Lactobacillus iners</italic> AB-1 to Human Fibronectin</article-title>
<subtitle>A Key Mediator for Persistence in the Vagina?</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>McMillan</surname>
<given-names>Amy</given-names>
</name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="aff1-1933719112466306">1</xref>
<xref ref-type="aff" rid="aff2-1933719112466306">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Macklaim</surname>
<given-names>Jean M.</given-names>
</name>
<degrees>BSc</degrees>
<xref ref-type="aff" rid="aff1-1933719112466306">1</xref>
<xref ref-type="aff" rid="aff3-1933719112466306">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burton</surname>
<given-names>Jeremy P.</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-1933719112466306">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Reid</surname>
<given-names>Gregor</given-names>
</name>
<degrees>PhD, MBA</degrees>
<xref ref-type="aff" rid="aff1-1933719112466306">1</xref>
<xref ref-type="aff" rid="aff2-1933719112466306">2</xref>
<xref ref-type="corresp" rid="corresp1-1933719112466306"/>
</contrib>
</contrib-group>
<aff id="aff1-1933719112466306">
<label>1</label>Canadian Research and Development Centre for Probiotics, Lawson Health Research Institute, St Joseph’s Health Care, London, ON, Canada</aff>
<aff id="aff2-1933719112466306">
<label>2</label>Departments of Microbiology and Immunology and Surgery, The University of Western Ontario, London, ON, Canada</aff>
<aff id="aff3-1933719112466306">
<label>3</label>Department of Biochemistry, The University of Western Ontario, London, ON, Canada</aff>
<author-notes>
<corresp id="corresp1-1933719112466306">Gregor Reid, Lawson Health Research Institute, 268 Grosvenor Street, Rm F2-116, London, ON, Canada, N6A 4V2 Email: <email>gregor@uwo.ca</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>20</volume>
<issue>7</issue>
<fpage>791</fpage>
<lpage>796</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>
<italic>Lactobacillus iners</italic> is prominent in the human vagina and is able to persist despite development of bacterial vaginosis and treatment with antibiotics. A probable factor in its persistent survival is its ability to be retained in the vaginal epithelia. Genome sequencing of the strain showed an organism deplete of many metabolic pathways, yet equipped with fibronectin (Fn)-binding adhesins. The objective of the present study was to assess the ability of <italic>L iners</italic> AB-1 to bind immobilized Fn. Results showed that the organism superiorly bound the protein compared to other species of <italic>Lactobacillus</italic> and known binders such as <italic>Staphylococcus aureus</italic>. Treatment of <italic>L iners</italic> cells by protease rendered its binding abilities to Fn nonfunctional. The findings indicate a mechanism of vaginal persistence for a <italic>Lactobacillus</italic> species, with implications for reproductive health.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Lactobacillus iners</italic>
</kwd>
<kwd>fibronectin</kwd>
<kwd>bacterial vaginosis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719112466306">
<title>Introduction</title>
<p>The vaginal microbiota plays an important role in maintaining female and fetal health, with over 250 bacterial species identified.<sup>
<xref ref-type="bibr" rid="bibr1-1933719112466306">1</xref>
<xref ref-type="bibr" rid="bibr2-1933719112466306"/>–<xref ref-type="bibr" rid="bibr3-1933719112466306">3</xref>
</sup> It has been known for some time that a healthy vagina is dominated by <italic>Lactobacillus</italic> species, in particular <italic>Lactobacillus iners</italic> and <italic>Lactobacillus</italic> <italic>crispatus</italic>. A shift from this state can result in aberrant conditions such as bacterial vaginosis (BV)<sup>
<xref ref-type="bibr" rid="bibr1-1933719112466306">1</xref>
<xref ref-type="bibr" rid="bibr2-1933719112466306"/>
<xref ref-type="bibr" rid="bibr3-1933719112466306"/>–<xref ref-type="bibr" rid="bibr4-1933719112466306">4</xref>
</sup> and aerobic vaginitis<sup>
<xref ref-type="bibr" rid="bibr5-1933719112466306">5</xref>
</sup> as well as urinary tract infection.<sup>
<xref ref-type="bibr" rid="bibr6-1933719112466306">6</xref>,<xref ref-type="bibr" rid="bibr7-1933719112466306">7</xref>
</sup>
</p>
<p>The predominant species in the vagina as determined by 16S ribosomal RNA gene sequencing is <italic>L iners</italic>.<sup>
<xref ref-type="bibr" rid="bibr2-1933719112466306">2</xref>,<xref ref-type="bibr" rid="bibr8-1933719112466306">8</xref>
<xref ref-type="bibr" rid="bibr9-1933719112466306"/>–<xref ref-type="bibr" rid="bibr10-1933719112466306">10</xref>
</sup> Due to its fastidious requirements, this species has been largely overlooked in the past bacteriologically based studies. In a deep sequencing study of women with BV, <italic>L iners</italic> was the only species to increase in number following metronidazole treatment, demonstrating its unique ability to persist in the fluctuating vaginal environments.<sup>
<xref ref-type="bibr" rid="bibr2-1933719112466306">2</xref>
</sup> <italic>Lactobacillus iners</italic> has also been shown in vitro to displace biofilms of <italic>Gardnerella vaginalis</italic>,<sup>
<xref ref-type="bibr" rid="bibr11-1933719112466306">11</xref>
</sup> a bacterium associated with BV.<sup>
<xref ref-type="bibr" rid="bibr2-1933719112466306">2</xref>,<xref ref-type="bibr" rid="bibr10-1933719112466306">10</xref>
</sup> Others have suggested that because <italic>L iners</italic> can be found in women with infection, the species is not protective,<sup>
<xref ref-type="bibr" rid="bibr4-1933719112466306">4</xref>,<xref ref-type="bibr" rid="bibr12-1933719112466306">12</xref>
</sup> but recent studies show that <italic>L iners</italic> changes its gene expression to adapt to BV conditions by increasing metabolic activity against carbohydrates (manuscript submitted). This suggests that <italic>L iners</italic> may provide a nidus for recovery from BV and restoration of homeostasis.</p>
<p>Adhesion is the first step in bacterial colonization of a surface and in the gastrointestinal tract <italic>Lactobacillus</italic> adhesion is commonly mediated by mucus-binding proteins.<sup>
<xref ref-type="bibr" rid="bibr13-1933719112466306">13</xref>
</sup> Adhesion is also believed to play a role in pathogen exclusion via blockage of their binding sites in the mucosa.<sup>
<xref ref-type="bibr" rid="bibr14-1933719112466306">14</xref>
</sup> The ability to produce adhesion proteins has been shown in the genome of <italic>L iners</italic> AB-1, potentially providing it with a means to colonize the vagina.<sup>
<xref ref-type="bibr" rid="bibr15-1933719112466306">15</xref>
</sup> Genomic sequencing of the strain <italic>L iners</italic> AB-1 revealed that it is the smallest <italic>Lactobacillus</italic> genome known to date (1.3 Mb), and lacks better known adhesion molecules common to other <italic>Lactobacillus</italic> species, none of which have the persistence capability of <italic>L iners</italic>. This suggests that <italic>L iners</italic> contains somewhat a unique mechanism to persist in the host.</p>
<p>A predicted fibronectin (Fn)-binding protein in <italic>L iners</italic> AB-1 was of interest as it contains a motif (fibronectin-binding protein A) common to pathogenic strains of <italic>Staphylococcus aureus</italic>, where it mediates adhesion and internalization into the host cells.<sup>
<xref ref-type="bibr" rid="bibr16-1933719112466306">16</xref>
</sup> Although there is no evidence that <italic>L iners</italic> internalizes into the host cells,<sup>
<xref ref-type="bibr" rid="bibr15-1933719112466306">15</xref>
</sup> protein predictions suggest <italic>L iners</italic> may adhere to the vaginal epithelium via Fn. Fibronectin is a 454 kDa glycoprotein found in a soluble form in the plasma and in an insoluble form in the extracellular matrix and attached to the surface of host cells. We demonstrate here that <italic>L iners</italic> AB-1 binds strongly to the human Fn and that this process is protein mediated.</p>
</sec>
<sec id="section2-1933719112466306" sec-type="materials|methods">
<title>Materials and Methods</title>
<p>The overall design of the experiments was to determine the extent of binding of <italic>L iners</italic> to Fn, to compare it to a well-known binder, <italic>S aureus</italic>, in order to better understand how the lactobacilli might utilize the glycoprotein for persistence in the vagina.</p>
<sec id="section3-1933719112466306">
<title>Strains and Growth Conditions</title>
<p>The strains used in this study are listed in <xref ref-type="table" rid="table1-1933719112466306">Table 1</xref>. <italic>Lactobacillus rhamnosus</italic> GR-1, <italic>L rhamnosus</italic> GG, <italic>L reuteri</italic> RC-14, and <italic>L crispatus</italic> American Type Culture Collection 33820 were grown in de Man, Rogosa, and Sharpe (MRS) agar and broth (Difco, Maryland), anerobically at 37°C under static conditions. <italic>Lactobacillus iners</italic> AB-1 was grown on Columbia blood agar (Difco), then subcultured in 10 mL of MRS broth and grown anerobically at 37°C overnight under static conditions. Growth of <italic>L iners</italic> AB-1 in MRS broth is shown in <xref ref-type="fig" rid="fig1-1933719112466306">Figure 1</xref>. <italic>Staphylococcus aureus</italic> MN8 was grown in brain heart infusion (Difco) agar and broth at 37°C aerobically with agitation.</p>
<fig id="fig1-1933719112466306" position="float">
<label>Figure 1.</label>
<caption>
<p>
<italic>Lactobacillus iners</italic> AB-1 grown in 10 mL de Man, Rogosa, and Sharpe (MRS) broth for 7 days. The bars represent standard deviation.</p>
</caption>
<graphic xlink:href="10.1177_1933719112466306-fig1.tif"/>
</fig>
<table-wrap id="table1-1933719112466306" position="float">
<label>Table 1.</label>
<caption>
<p>Bacterial Strains Used in This Study</p>
</caption>
<graphic alternate-form-of="table1-1933719112466306" xlink:href="10.1177_1933719112466306-table1.tif"/>
<table>
<thead>
<tr>
<th>Strain</th>
<th>Source/Relevant Characteristics</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<italic>Lactobacillus iners</italic> AB-1</td>
<td>Vaginal isolate; from healthy woman<sup>
<xref ref-type="bibr" rid="bibr15-1933719112466306">15</xref>
</sup>
</td>
</tr>
<tr>
<td>
<italic>Lactobacillus rhamnosus</italic> GR-1</td>
<td>Distal urethral isolate; from a healthy woman<sup>
<xref ref-type="bibr" rid="bibr17-1933719112466306">17</xref>
</sup>
</td>
</tr>
<tr>
<td>
<italic>Lactobacillus rhamnosus</italic> GG</td>
<td>Human feces isolate<sup>
<xref ref-type="bibr" rid="bibr18-1933719112466306">18</xref>
</sup>
</td>
</tr>
<tr>
<td>
<italic>Lactobacillus reuteri</italic> RC-14</td>
<td>Vaginal isolate; from a healthy woman<sup>
<xref ref-type="bibr" rid="bibr17-1933719112466306">17</xref>
</sup>
</td>
</tr>
<tr>
<td>
<italic>Lactobacillus crispatus</italic> ATCC 33820</td>
<td>Vaginal isolate<sup>
<xref ref-type="bibr" rid="bibr19-1933719112466306">19</xref>
</sup>
</td>
</tr>
<tr>
<td>
<italic>Staphylococcus aureus</italic> MN8</td>
<td>Clinical isolate from patient with menstrual toxic shock syndrome (TSS)<sup>
<xref ref-type="bibr" rid="bibr20-1933719112466306">20</xref>
</sup>
</td>
</tr>
</tbody>
</table>
</table-wrap>
<sec id="section4-1933719112466306">
<title>Fibronectin adhesion assay</title>
<p>Binding of bacteria to immobilized Fn was measured according to the methods of Munoz-Provencio et al.<sup>
<xref ref-type="bibr" rid="bibr21-1933719112466306">21</xref>
</sup> Briefly, 96-well Polysorp plates (Nunc, Rochester, New York) were coated with 50 µg/mL human Fn (Sigma Chem. Co, St Louis, Missouri) in carbonate/bicarbonate buffer 50 mmol/L pH 9.6 and incubated at 4°C overnight. The wells were washed 3 times with 100 µL phosphate-buffered saline (PBS; pH 7.4), then blocked with 100 µL of PBS + 1% Tween 20 for 1 hour. All strains were grown to late exponential phase (54 hours for <italic>L iners</italic> AB-1, 5-6 hours for all other strains tested), washed 3 times with PBS, and resuspended in PBS to an optical density that represented 10<sup>7</sup> colony-forming unit (CFU)/mL as determined previously by the growth curves. Then 100 µL of each strain was added to each well and incubated at 37°C for 2 hours. After incubation, nonadherent cells were removed by 3 washes with 200 µL PBS + 0.05% Tween 20. The adhered cells were stained with 100 µL of 1 mg/mL crystal violet for 45 minutes. After washing, the colorant was released with 100 µL citrate buffer (50 mmol/L, pH 4.0) and the absorbance at 600 nm was measured in a Multiskan Ascent plate reader (Thermo-Scientific, Rockford). Drop dilution plates using 10 µL of the culture and series of 10 times dilutions were performed simultaneously with binding assays to enumerate bacterial numbers upon addition to Fn-coated plates. Experiments were repeated 3 times and in triplicate.</p>
<p>The effect of protease treatment was assayed by incubating cells with 100 µg/mL proteinase K for 1 hour at 37°C followed by 1 hour incubation with 1 mmol/L phenylmethanesulfonylfluoride (PMSF) to inactivate proteinase K. The cells were then transferred to Fn-coated plate. Experiments were repeated twice and in duplicate. Wells without Fn were run as controls in all the experiments and their absorbance values were subtracted from the Fn-coated wells. The PBS alone was included in all experiments to account for any Fn binding by PBS.</p>
</sec>
<sec id="section5-1933719112466306">
<title>Bacterial binding to Fn-coated cover slips</title>
<p>Binding of bacteria to Fn-coated cover slips was determined by coating glass cover slips overnight with 50 μg/mL of Fn in PBS + 0.05% Tween 20 at 4°C. The slips (VWR 18 mm glass) were washed 3 times with 1 mL PBS and blocked with 1 mL PBS + 1% Tween 20 for 1 hour. The cells were grown to late exponential phase, washed twice with PBS, and diluted to a concentration of 10<sup>7</sup> CFU/mL with PBS. The numbers were confirmed by drop plating. Then 1 mL of these cultures was added to separate cover slips and incubated for 2 hours at 37°C. Nonadherent cells were removed by 3 washes with PBS + 0.05% Tween 20. The cover slips were then Gram stained and adherent cells were viewed under a Zeiss Axioscop HBO50 light microscope under ×100 objective. Cover slips without Fn were run as controls in all the experiments. Five fields of view were recorded for each cover slip and biological replicates were repeated three times to confirm the results.</p>
</sec>
</sec>
<sec id="section6-1933719112466306">
<title>Statistical Analysis</title>
<p>Statistical analysis was performed on all data from binding assays using the GraphPad Prism 4 program (GraphPad Software, Inc., La Jolla, California). The data fitted a normal distribution and were therefore appropriate for analysis of variance (ANOVA) testing. Differences between the normally distributed means were compared using a 1-way ANOVA analysis with a Tukeys post hoc test. Differences in binding were considered significant with <italic>P</italic> values of &lt;.05.</p>
</sec>
</sec>
<sec id="section7-1933719112466306">
<title>Results</title>
<p>
<italic>Lactobacillus iners</italic> AB-1 bound to Fn-coated polystyrene plates in significantly greater amounts than all strains tested (<xref ref-type="fig" rid="fig2-1933719112466306">Figure 2</xref>). The effect of proteinase K, a serine protease, was determined by incubating bacteria with proteinase K followed by the protease inhibitor PMSF before addition of cells to Fn-coated plates. Proteinase K treatment significantly reduced binding of <italic>L iners</italic> AB-1 to Fn (<italic>P</italic> &lt; .05; <xref ref-type="fig" rid="fig3-1933719112466306">Figure 3</xref>).</p>
<fig id="fig2-1933719112466306" position="float">
<label>Figure 2.</label>
<caption>
<p>Bacterial binding to immobilized fibronectin as measured by optical density at 600 nm (OD600). All strains were added to fibronectin-coated plates at a concentration of 10<sup>7</sup> CFU/mL unless indicated and bacterial numbers were confirmed by drop plating. Binding by<italic> Lactobacillus iners</italic> AB-1 is significantly greater than all strains (<italic>P</italic> &lt; .05). The bars represent standard deviation.</p>
</caption>
<graphic xlink:href="10.1177_1933719112466306-fig2.tif"/>
</fig>
<fig id="fig3-1933719112466306" position="float">
<label>Figure 3.</label>
<caption>
<p>Effect of proteinase K pretreatment on adhesion to immobilized fibronectin by <italic>Lactobacillus iners</italic> AB-1. Phenylmethanesulfonylfluoride is a proteinase K inhibitor. <italic>Lactobacillus iners</italic> AB-1 binding was significantly reduced by proteinase K pretreatment (<italic>P</italic> &lt; .05). The bars represent standard deviation.</p>
</caption>
<graphic xlink:href="10.1177_1933719112466306-fig3.tif"/>
</fig>
<p>Photomicrograph images of the cells adhering to Fn-coated and uncoated cover slips are shown in <xref ref-type="fig" rid="fig3-1933719112466306">Figure 3</xref> and bacterial cells counts in <xref ref-type="table" rid="table2-1933719112466306">Table 2</xref>. Adhesion of<italic> L iners</italic> AB-1 and <italic>S aureus</italic> MN8 was enhanced by coating slips with Fn. There was no difference in adhesion to Fn of <italic>L iners</italic> AB-1 compared to <italic>S aureus</italic> (<italic>P</italic> &gt; .05). The addition of Fn had no effect on the adhesion of <italic>L crispatus</italic> (<italic>P</italic> &gt; .05).</p>
<table-wrap id="table2-1933719112466306" position="float">
<label>Table 2.</label>
<caption>
<p>Bacterial Adhesion to Fibronectin-Coated Cover Slips Cell Counts<sup>a</sup>
</p>
</caption>
<graphic alternate-form-of="table2-1933719112466306" xlink:href="10.1177_1933719112466306-table2.tif"/>
<table>
<thead>
<tr>
<th>Strain</th>
<th>Fibronectin</th>
<th>No Fibronectin</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<italic>Staphylococcus aureus</italic> MN8</td>
<td>299 ± 28.2</td>
<td>54 ± 19.7</td>
</tr>
<tr>
<td>
<italic>Lactobacillus iners</italic> AB-1</td>
<td>341 ± 27.7</td>
<td>33 ± 19.2</td>
</tr>
<tr>
<td>
<italic>Lactobacillus crispatus</italic> 33820</td>
<td>8 ± 3.1</td>
<td>20 ± 11.0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1933719112466306">
<p>
<sup>a</sup>Counts represent an average of 3 fields of view ± standard deviation.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section8-1933719112466306">
<title>Discussion</title>
<p>The concentration of Fn in the vagina has been reported from as high as 90 to 140 pg/mL during menses to 3 to 5 pg/mL at the end of the menstrual cycle.<sup>
<xref ref-type="bibr" rid="bibr22-1933719112466306">22</xref>
</sup> As <italic>L iners</italic> possesses a predicted Fn-binding protein and adhesion is the first step in colonization of a surface, we hypothesized that strong adhesion to Fn could be contributing to its persistence in the human vagina.<sup>
<xref ref-type="bibr" rid="bibr15-1933719112466306">15</xref>
</sup> <italic>Lactobacillus iners</italic> AB-1 bound significantly greater to human Fn compared to other <italic>Lactobacillus</italic> strains tested, including vaginal probiotic <italic>L rhamnosus</italic> GR-1 and <italic>L reuteri</italic> RC-14, and gut probiotic <italic>L rhamnosus</italic> GG (<xref ref-type="fig" rid="fig4-1933719112466306">Figure 4</xref>), none of which are able to persist long term in the vagina. However, since strains <italic>L rhamnosus</italic> GR-1 and <italic>L reuteri</italic> RC-14 help restore the vaginal microbiota back to a healthy state,<sup>
<xref ref-type="bibr" rid="bibr23-1933719112466306">23</xref>,<xref ref-type="bibr" rid="bibr24-1933719112466306">24</xref>
</sup> they must use different adhesion mechanisms, such as extracellular polysaccharides or metabolic pathways, in the vagina.</p>
<fig id="fig4-1933719112466306" position="float">
<label>Figure 4.</label>
<caption>
<p>Bacterial adhesion to fibronectin-coated cover slips. A, <italic>Lactobacillus iners</italic> + fibronectin. B, <italic>Lactobacillus iners</italic> no fibronectin. C, <italic>Staphylococcus aureus</italic> + fibronectin. D, <italic>Staphylococcus aureus</italic> no fibronectin. E,<italic> Lactobacillus crispatus</italic> + fibronectin. F, <italic>Lactobacillus crispatus</italic> no fibronectin.</p>
</caption>
<graphic xlink:href="10.1177_1933719112466306-fig4.tif"/>
</fig>
<p>In relation to pregnancy, fetal Fn is found in the amniotic fluid, placental tissue, and the decidua basalis, but its presence in the cervicovaginal secretions between 22 and 37 weeks may be due to disruption of the chorionic–decidual interface secondary to infection.<sup>
<xref ref-type="bibr" rid="bibr25-1933719112466306">25</xref>
</sup> Hypothetically, <italic>L iners</italic> could bind to Fn and potentially counter pathogenesis thereby extending the duration of the pregnancy. Since <italic>L iners</italic> has only relatively recently been discovered and detected using molecular methodologies, no studies have looked for its presence during elevated Fn and infection. Investigations of this nature perhaps warrant undertaking.</p>
<p>This is the first report of <italic>L iners</italic> having such strong adhesion to a mucosal protein. This trend was confirmed by viewing cells bound to Fn-coated cover slips under a light microscope (<xref ref-type="fig" rid="fig4-1933719112466306">Figure 4</xref>). Interestingly, <italic>L iners</italic> AB-1 bound equally or stronger to Fn compared to <italic>S aureus</italic> MN8, a species well studied for its Fn-binding properties.<sup>
<xref ref-type="bibr" rid="bibr16-1933719112466306">16</xref>
</sup> <italic>Lactobacillus crispatus</italic>, another member of the core vaginal microbiota, lacks Fn-binding properties, indicating that <italic>L iners</italic> and <italic>L crispatus</italic> use different adhesion mechanisms to colonize the same environment. This is particularly interesting since <italic>L crispatus</italic> strains do not appear to persist to the extent of <italic>L iners</italic>, and their displacement coincides with the onset of BV.<sup>
<xref ref-type="bibr" rid="bibr1-1933719112466306">1</xref>
</sup> When candidate probiotic strain <italic>L crispatus</italic> CTV-05 did colonize hosts who lacked indigenous <italic>L crispatus</italic>, a healthy state was maintained.<sup>
<xref ref-type="bibr" rid="bibr26-1933719112466306">26</xref>
</sup> It is not clear how BV organisms induce <italic>L crispatus</italic> and not <italic>L iners</italic> displacement, but the avidity of adhesion to Fn of the latter likely plays a role. A recent study using atomic force microscopy highlighted the weaker adhesion of <italic>L crispatus</italic> and <italic>L jensenii</italic> and suggested that for <italic>Lactobacillus</italic> species to displace pathogens, they need to display strong adhesion forces.<sup>
<xref ref-type="bibr" rid="bibr27-1933719112466306">27</xref>
</sup> This is not ubiquitous across <italic>Lactobacillus</italic>, and Nagy et al<sup>
<xref ref-type="bibr" rid="bibr28-1933719112466306">28</xref>
</sup> found only 9 (16.7%) of the 54 vaginal <italic>Lactobacillus</italic> isolates that bound Fn at pH 7.2; however, <italic>L iners</italic> was not included as it had not yet been discovered. They also observed that adhesion to Fn increased when the pH was lowered to 4.0. This may help explain the loss of some <italic>Lactobacillus</italic> species during BV, where the pH is elevated. It also suggests that <italic>L iners</italic> is able to persist during incidences of BV in part due to its ability to bind Fn at a more neutral pH as shown in our study.</p>
<p>To determine whether Fn adhesion by <italic>L iners</italic> was protein mediated, we pretreated cells with the serine protease, proteinase K. This treatment significantly reduced binding to Fn (<italic>P</italic> &lt; .05), confirming that Fn adherence by <italic>L iners</italic> AB-1 is protein mediated. A predicted Fn-binding protein (LINAB1_0564) in <italic>L iners</italic> AB-1 could be contributing to this interaction. This protein has 34% amino acid similarity to Fn-binding protein of <italic>S aureus</italic> MN8. Furthermore, analysis of the transcriptome of <italic>L iners</italic> has revealed that this gene is expressed in both healthy patients and those with BV (manuscript submitted), indicating the protein may be used during both conditions to adhere to the vaginal mucosa and colonize the vagina.</p>
<p>In summary, the persistence of<italic> L iners</italic> in the vagina despite the presence of other lactobacilli and pathogens or antibiotics could be due to its strong adhesion to Fn. If clones of this species do indeed form an environment that allows restitution of a <italic>Lactobacillus</italic> microbiota that protects against disease, future probiotic strains, such as those used against human immunodeficiency virus<sup>
<xref ref-type="bibr" rid="bibr29-1933719112466306">29</xref>,<xref ref-type="bibr" rid="bibr30-1933719112466306">30</xref>
</sup> or the ones devised to compete with Fn-binding <italic>Trichomonas</italic> <sup>
<xref ref-type="bibr" rid="bibr31-1933719112466306">31</xref>
</sup> could benefit from cloning of the <italic>L iners</italic> Fn-binding protein.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The technical assistance from Shannon Mifflin is acknowledged.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-1933719112466306">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1933719112466306">
<label>Funding</label>
<p>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: CIHR VoGue project.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719112466306">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fredricks</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Fiedler</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Marrazzo</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Molecular identification of bacteria associated with bacterial vaginosis</article-title>. <source>N Engl J Med</source>. <year>2005</year>;<volume>353</volume>(<issue>18</issue>):<fpage>1899</fpage>–<lpage>1911</lpage>.</citation>
</ref>
<ref id="bibr2-1933719112466306">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hummelen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fernandes</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Macklaim</surname>
<given-names>JM</given-names>
</name>
<etal/>
</person-group> <article-title>Deep sequencing of the vaginal microbiota of women with HIV</article-title>. <source>PLoS One</source>. <year>2010</year>;<volume>5</volume>(<issue>8</issue>):<fpage>e12078</fpage>.</citation>
</ref>
<ref id="bibr3-1933719112466306">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gajer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Abdo</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group> <article-title>Vaginal microbiome of reproductive-age women</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume>(<issue>suppl 1</issue>):<fpage>4680</fpage>–<lpage>4687</lpage>.</citation>
</ref>
<ref id="bibr4-1933719112466306">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamrakar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Furuta</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group> <article-title>Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women</article-title>. <source>BMC Infect Dis</source>. <year>2007</year>;<volume>7</volume>:<fpage>128</fpage>.</citation>
</ref>
<ref id="bibr5-1933719112466306">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donders</surname>
<given-names>GG</given-names>
</name>
<name>
<surname>Vereecken</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bosmans</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dekeersmaecker</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Salembier</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Spitz</surname>
<given-names>B</given-names>
</name>
</person-group>. <article-title>Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis</article-title>. <source>BJOG</source>. <year>2002</year>;<volume>109</volume>(<issue>1</issue>):<fpage>34</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr6-1933719112466306">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cadieux</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Burton</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Devillard</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Lactobacillus by-products inhibit the growth and virulence of uropathogenic <italic>Escherichia coli</italic>
</article-title>. <source>J Physiol Pharmacol</source>. <year>2009</year>;<volume>60</volume>(<issue>suppl 6</issue>):<fpage>13</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr7-1933719112466306">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharami</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Afrakhteh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Shakiba</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Urinary tract infections in pregnant women with bacterial vaginosis</article-title>. <source>J Obstet Gynaecol</source>. <year>2007</year>;<volume>27</volume>(<issue>3</issue>):<fpage>252</fpage>–<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr8-1933719112466306">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burton</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Cadieux</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation</article-title>. <source>Appl Environ Microbiol</source>. <year>2003</year>;<volume>69</volume>(<issue>1</issue>):<fpage>97</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr9-1933719112466306">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sobel</surname>
<given-names>JD</given-names>
</name>
</person-group>. <article-title>Bacterial vaginosis</article-title>. <source>Annu Rev Med</source>. <year>2000</year>;<volume>51</volume>:<fpage>349</fpage>–<lpage>356</lpage>.</citation>
</ref>
<ref id="bibr10-1933719112466306">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hansmann</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>CC</given-names>
</name>
<etal/>
</person-group> <article-title>The vaginal bacterial communities of Japanese women resemble those of women in other racial groups</article-title>. <source>FEMS Immunol Med Microbiol</source>. <year>2010</year>;<volume>58</volume>(<issue>2</issue>):<fpage>169</fpage>–<lpage>181</lpage>.</citation>
</ref>
<ref id="bibr11-1933719112466306">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bocking</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Challis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms</article-title>. <source>Colloids Surf B Biointerfaces</source>. <year>2007</year>;<volume>55</volume>(<issue>2</issue>):<fpage>138</fpage>–<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr12-1933719112466306">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>JR</given-names>
</name>
</person-group>. <article-title>Comparison of main Lactobacillus species between healthy women and women with bacterial vaginosis</article-title>. <source>Chin Med J (Engl)</source>. <year>2009</year>;<volume>122</volume>(<issue>22</issue>):<fpage>2748</fpage>–<lpage>2751</lpage>.</citation>
</ref>
<ref id="bibr13-1933719112466306">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velez</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>De Keersmaecker</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Vanderleyden</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Adherence factors of Lactobacillus in the human gastrointestinal tract</article-title>. <source>FEMS Microbiol Lett</source>. <year>2007</year>;<volume>276</volume>(<issue>2</issue>):<fpage>140</fpage>–<lpage>148</lpage>.</citation>
</ref>
<ref id="bibr14-1933719112466306">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irvine</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Hummelen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hekmat</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Looman</surname>
<given-names>CW</given-names>
</name>
<name>
<surname>Habbema</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS</article-title>. <source>J Clin Gastroenterol</source>. <year>2010</year>;<volume>44</volume>(<issue>9</issue>):<fpage>e201</fpage>–<lpage>e205</lpage>.</citation>
</ref>
<ref id="bibr15-1933719112466306">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macklaim</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Gloor</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Anukam</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Cribby</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>At the crossroads of vaginal health and disease, the genome sequence of <italic>Lactobacillus iners</italic> AB-1</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2011</year>;<volume>108</volume>(<issue>suppl 1</issue>):<fpage>4688</fpage>–<lpage>4695</lpage>.</citation>
</ref>
<ref id="bibr16-1933719112466306">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sinha</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Francois</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group> <article-title>Fibronectin-binding protein acts as Staphylococcus aureus invasin via fibronectin bridging to integrin alpha5beta1</article-title>. <source>Cell Microbiol</source>. <year>1999</year>;<volume>1</volume>(<issue>2</issue>):<fpage>101</fpage>–<lpage>117</lpage>.</citation>
</ref>
<ref id="bibr17-1933719112466306">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Bruce</surname>
<given-names>AW</given-names>
</name>
</person-group>. <article-title>Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract</article-title>. <source>J Urol</source>. <year>1987</year>;<volume>138</volume>(<issue>2</issue>):<fpage>330</fpage>–<lpage>335</lpage>.</citation>
</ref>
<ref id="bibr18-1933719112466306">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jacobus</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>Deneke</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gorbach</surname>
<given-names>SL</given-names>
</name>
</person-group>. <article-title>Antimicrobial substance from a human Lactobacillus strain</article-title>. <source>Antimicrob Agents Chemother</source>. <year>1987</year>;<volume>31</volume>(<issue>8</issue>):<fpage>1231</fpage>–<lpage>1233</lpage>.</citation>
</ref>
<ref id="bibr19-1933719112466306">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skerman</surname>
<given-names>VB</given-names>
</name>
</person-group>. <article-title>Approved list of bacterial names</article-title>. <source>Int J Syst Bacteriol</source>. <year>1980</year>;<volume>30</volume>:<fpage>225</fpage>–<lpage>420</lpage>.</citation>
</ref>
<ref id="bibr20-1933719112466306">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schlievert</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Blomster</surname>
<given-names>DA</given-names>
</name>
</person-group>. <article-title>Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors</article-title>. <source>J Infect Dis</source>. <year>1983</year>;<volume>147</volume>(<issue>2</issue>):<fpage>236</fpage>–<lpage>242</lpage>.</citation>
</ref>
<ref id="bibr21-1933719112466306">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munoz-Provencio</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Perez-Martinez</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Monedero</surname>
<given-names>V</given-names>
</name>
</person-group>. <article-title>Characterization of a fibronectin-binding protein from Lactobacillus casei BL23</article-title>. <source>J Appl Microbiol</source>. <year>2010</year>;<volume>108</volume>(<issue>3</issue>):<fpage>1050</fpage>–<lpage>1059</lpage>.</citation>
</ref>
<ref id="bibr22-1933719112466306">
<label>22</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name>
<surname>Antonas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yajko</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hardley</surname>
<given-names>W.</given-names>
</name>
</person-group> <article-title>Assay of fibronectin in vaginal fluid and the role of fibronectin in bacterial colonization</article-title>. <conf-name>Annual Meeting of the American Society of Microbiology</conf-name>. <year>1983</year>: <comment>Abstract no. 1310</comment>.</citation>
</ref>
<ref id="bibr23-1933719112466306">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Franceschini</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Patta</surname>
<given-names>MC</given-names>
</name>
<etal/>
</person-group> <article-title>Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and <italic>Lactobacillus reuteri</italic> RC-14: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Can J Microbiol</source>. <year>2009</year>;<volume>55</volume>(<issue>2</issue>):<fpage>133</fpage>–<lpage>138</lpage>.</citation>
</ref>
<ref id="bibr24-1933719112466306">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Charbonneau</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Erb</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Oral use of <italic>Lactobacillus rhamnosus</italic> GR-1 and <italic>L</italic>. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women</article-title>. <source>FEMS Immunol Med Microbiol</source>. <year>2003</year>;<volume>35</volume>(<issue>2</issue>):<fpage>131</fpage>–<lpage>134</lpage>.</citation>
</ref>
<ref id="bibr25-1933719112466306">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dutta</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Norman</surname>
<given-names>JE</given-names>
</name>
</person-group>. <article-title>The efficacy of fetal fibronectin testing in minimising hospital admissions, length of hospital stay and cost savings in women presenting with symptoms of pre-term labour</article-title>. <source>J Obstet Gynaecol</source>. <year>2010</year>;<volume>30</volume>(<issue>8</issue>):<fpage>768</fpage>–<lpage>773</lpage>.</citation>
</ref>
<ref id="bibr26-1933719112466306">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonio</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Meyn</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Busse</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hillier</surname>
<given-names>SL</given-names>
</name>
</person-group>. <article-title>Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous lactobacilli</article-title>. <source>J Infect Dis</source>. <year>2009</year>;<volume>199</volume>(<issue>10</issue>):<fpage>1506</fpage>–<lpage>1513</lpage>.</citation>
</ref>
<ref id="bibr27-1933719112466306">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Younes</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>van der Mei</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>van den Heuvel</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Busscher</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Adhesion forces and coaggregation between vaginal staphylococci and lactobacilli</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>5</issue>):<fpage>e36917</fpage>.</citation>
</ref>
<ref id="bibr28-1933719112466306">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagy</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Froman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mardh</surname>
<given-names>PA</given-names>
</name>
</person-group>. <article-title>Fibronectin binding of Lactobacillus species isolated from women with and without bacterial vaginosis</article-title>. <source>J Med Microbiol</source>. <year>1992</year>;<volume>37</volume>(<issue>1</issue>):<fpage>38</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr29-1933719112466306">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pusch</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kalyanaraman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>LD</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Ramratnam</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Boden</surname>
<given-names>D</given-names>
</name>
</person-group>. <article-title>An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli</article-title>. <source>AIDS</source>. <year>2006</year>;<volume>20</volume>(<issue>15</issue>):<fpage>1917</fpage>–<lpage>1922</lpage>.</citation>
</ref>
<ref id="bibr30-1933719112466306">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>CC</given-names>
</name>
</person-group>. <article-title>Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic <italic>Lactobacillus reuteri</italic> RC-14</article-title>. <source>Cell Microbiol</source>. <year>2007</year>;<volume>9</volume>(<issue>1</issue>):<fpage>120</fpage>–<lpage>130</lpage>.</citation>
</ref>
<ref id="bibr31-1933719112466306">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alderete</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Benchimol</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lehker</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Crouch</surname>
<given-names>ML</given-names>
</name>
</person-group>. <article-title>The complex fibronectin—<italic>Trichomonas vaginalis</italic> interactions and trichomonosis</article-title>. <source>Parasitol Int</source>. <year>2002</year>;<volume>51</volume>(<issue>3</issue>):<fpage>285</fpage>–<lpage>292</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>